Trial site
Great Lakes Clinical Trials - Andersonville
- 5running trials
- 5closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease6 trials
- Obesity4 trials
- Type 2 diabetes1 trial
- Phase
- Phase 36 trials
- Phase 24 trials
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company9 trials
- Bristol-Myers Squibb1 trial
Running trials
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
Closed trials
Completed
Completed
Completed
A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
Completed
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Site data: ClinicalTrials.govUpdated 18 Nov 2026